These Ebola Researchers Are Stuck in US Due to Trump’s Funding Cuts
The Centers for Research in Emerging Infectious Diseases were launched during the Covid-19 pandemic. The group lost its funding under Trump in part due to conspiracy theories.
Supercharging Immune Cells May Help Control HIV Long-Term
CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV.
We Now Know How Many People the CDC Is Monitoring for Hantavirus
There are no confirmed cases in the US, but 41 people who were potentially exposed to the Andes virus are in quarantine or being monitored for symptoms.
Inside the Race to Develop a Test for the Rare Andes Hantavirus
A University of Nebraska lab has developed a test that can detect the virus before symptoms become severe. Now, it's ready to start testing those returning to the US after a cruise outbreak.
All Your Hantavirus Questions, Answered by an Infectious Disease Expert
Here’s what you need to know, from why the cruise ship outbreak won’t spark the next pandemic to how hantavirus spreads.
Why the Hantavirus Cruise Ship Outbreak Isn’t Likely to Become a Global Crisis
While the outbreak aboard a cruise ship in the Atlantic is concerning, the virus isn’t easily transmitted through casual contact.
RFK Jr.’s New Podcast Is as Weird as You’d Expect
The first two episodes of Robert F. Kennedy Jr.’s new podcast feature him discoursing on food with a reality-TV chef and, for some reason, Mike Tyson. Vaccines are not on the agenda.
How AI Could Help Combat Antibiotic Resistance
At WIRED Health, British surgeon Ara Darzi said AI is set to transform the diagnosis and treatment of drug-resistant infections. But a lack of incentives means innovation may not reach patients.
A Brain Implant for Depression Is About to Be Tested in Humans
While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is targeting mental health disorders.
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”